July 2026
Published Jul 12, 2026RCTs
The FIGARO-DKD trial subgroup analysis evaluated finerenone in patients with type 2 diabetes and chronic kidney disease, finding significant reductions in kidney failure risk.
Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Incidence of hyperkalemiaTime to cardiovascular deathTime to kidney failure, sustained eGFR decline ≥40% from baseline, or kidney-related death
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the Fos Biomedical non-transdermal patch system's effects on cardio-metabolic health and sleep quality, finding no significant improvements in key outcomes.
Interventions
Fos Biomedical Non-transdermal Patch System
Outcomes
C-reactive proteinChange in body composition after 12 weeks of treatmentEndothelial function+4 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effects of oral multivitamins and multiminerals (OMVM) in patients with diabetes and a history of myocardial infarction. The findings indicated no significant differences in major cardiovascular outcomes between the OMVM and placebo groups.
Interventions
Oral multivitamins and multiminerals (OMVM)
Outcomes
Adverse events incidenceAll-cause mortalityComposite of CV death, non-fatal myocardial infarction, or non-fatal stroke+3 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated a hybrid telemedicine approach for adults with type 1 diabetes against standard clinical practice, finding a significant reduction in HbA1c levels.
Interventions
Hybrid closed-loop system
Outcomes
Adverse events incidenceGlucose variabilityHbA1c+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the True Vie I3 Continuous Glucose Monitoring System in adults with diabetes, finding high agreement rates and minimal pain during sensor use.
Interventions
Continuous glucose monitoring
Outcomes
Agreement Rates for Arm SensorsAgreement rates for abdomen sensorsMean Absolute Relative Difference (MARD) for Abdomen Sensors+5 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
A value-based hospital-community-family linkage program improved blood glucose management in elderly patients with type 2 diabetes compared to conventional management.
Interventions
Structured multidisciplinary case management
Outcomes
Anxiety scoreAverage daily dose of antidiabetic medications required by participantsFasting Plasma Glucose (FPG)+1 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study investigated the effects of liraglutide on plasma GDF15 levels in patients with type 2 diabetes, finding no significant changes in GDF15 levels.
Outcomes
Body weightGrowth differentiation factor 15
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study examined the effects of Metformin and Liraglutide on the gut microbiome in youth with type 2 diabetes, revealing significant changes in microbial abundance and metabolic markers.
Interventions
MetforminMetformin + Liraglutide
Outcomes
Fasting Plasma Glucose (FPG)Plasma cholic secondary bile acidsRelative abundance of Bacteroides fragilis+4 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated an mHealth-based diabetes prevention program for mothers with abdominal obesity, finding significant reductions in waist circumference and diabetes risk scores.
Interventions
Peer-support lifestyle program
Outcomes
BMIDaily active minutesDaily calorie consumption+11 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
The ENERGISED trial evaluated a mobile health intervention aimed at increasing physical activity among individuals with prediabetes and type 2 diabetes.
Interventions
Digital physician-pharmacist collaborative care
Outcomes
Acceptability of text messages in diabetes managementPhysical activity level (MET-minutes per week)Reduced sedentary time
Added to Dediabetes Jul 12, 2026
